X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4465) 4465
Book Review (1280) 1280
Publication (382) 382
Newsletter (177) 177
Book Chapter (48) 48
Book / eBook (15) 15
Conference Proceeding (8) 8
Magazine Article (4) 4
Dissertation (3) 3
Newspaper Article (2) 2
Reference (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (3810) 3810
humans (3741) 3741
epstein-barr-virus (2241) 2241
female (2035) 2035
male (1999) 1999
epstein-barr virus (1897) 1897
adult (1539) 1539
middle aged (1324) 1324
oncology (1039) 1039
risk factors (1018) 1018
adolescent (944) 944
cancer (930) 930
aged (879) 879
health aspects (864) 864
child (838) 838
infection (808) 808
epidemiology (743) 743
epstein-barr virus infections - epidemiology (705) 705
research (629) 629
herpesvirus 4, human - isolation & purification (618) 618
viruses (612) 612
child, preschool (603) 603
epstein-barr virus infections - complications (582) 582
immunology (567) 567
nasopharyngeal carcinoma (546) 546
herpesvirus 4, human - genetics (544) 544
lymphomas (503) 503
prevalence (500) 500
disease (499) 499
incidence (496) 496
infections (484) 484
infectious diseases (476) 476
young adult (465) 465
ebv (446) 446
infant (435) 435
analysis (430) 430
epstein-barr virus infections - virology (422) 422
lymphoma (422) 422
polymerase chain reaction (408) 408
children (403) 403
risk (397) 397
herpesvirus 4, human - immunology (392) 392
hematology (391) 391
prognosis (391) 391
virus diseases (387) 387
virology (384) 384
abridged index medicus (379) 379
pathology (377) 377
case-control studies (372) 372
dna (364) 364
transplantation (362) 362
animals (361) 361
retrospective studies (358) 358
carcinoma (356) 356
medical research (344) 344
expression (343) 343
diagnosis (339) 339
antibodies (336) 336
aged, 80 and over (327) 327
microbiology (325) 325
hemic and lymphatic diseases (311) 311
care and treatment (307) 307
epstein–barr virus (305) 305
antibodies, viral - blood (294) 294
cytomegalovirus (294) 294
multiple sclerosis (290) 290
pediatrics (288) 288
development and progression (285) 285
surgery (280) 280
genetic aspects (279) 279
tumors (277) 277
association (275) 275
epstein-barr virus infections - immunology (275) 275
research article (256) 256
immunohistochemistry (255) 255
risk-factors (244) 244
in situ hybridization (241) 241
medicine (233) 233
article (230) 230
medicine, experimental (225) 225
viral load (221) 221
epstein-barr virus infections - diagnosis (219) 219
lymphocytes (216) 216
medicine & public health (216) 216
antigens (209) 209
hiv (208) 208
clinical neurology (206) 206
polymerase-chain-reaction (205) 205
pathogenesis (203) 203
nasopharyngeal neoplasms - virology (197) 197
studies (197) 197
deoxyribonucleic acid--dna (193) 193
herpesvirus 4, human (193) 193
public, environmental & occupational health (192) 192
review (190) 190
treatment outcome (189) 189
non-hodgkins-lymphoma (187) 187
aids/hiv (186) 186
t cells (186) 186
age factors (185) 185
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4592) 4592
French (36) 36
Spanish (28) 28
Chinese (15) 15
Russian (10) 10
German (7) 7
Japanese (6) 6
Polish (5) 5
Turkish (3) 3
Ukrainian (3) 3
Danish (2) 2
Hungarian (1) 1
Italian (1) 1
Korean (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Journal Article
Journal Article
Lancet Neurology, The, ISSN 1474-4422, 2011, Volume 10, Issue 5, pp. 436 - 445
Summary Background HLA-DRB1*15 genotype, previous infection with Epstein-Barr virus, and vitamin D insufficiency are susceptibility factors for multiple... 
Neurology | ANTIBODIES | RISK-FACTORS | MCDONALD CRITERIA | DIAGNOSTIC-CRITERIA | CHILDHOOD | EPSTEIN-BARR-VIRUS | CLINICAL NEUROLOGY | FEATURES | Multiple Sclerosis - diagnosis | Prospective Studies | Age Factors | Follow-Up Studies | Demyelinating Diseases - genetics | Humans | Child, Preschool | Male | Multiple Sclerosis - epidemiology | HLA-DR Antigens - genetics | Demyelinating Diseases - diagnosis | Canada - epidemiology | Epstein-Barr Virus Infections - genetics | Female | Child | Epstein-Barr Virus Infections - epidemiology | Acute Disease | Genetic Predisposition to Disease | Risk Factors | Demyelinating Diseases - epidemiology | Multiple Sclerosis - genetics | Environmental Exposure - adverse effects | Genetic Markers - genetics | HLA-DRB1 Chains | Adolescent | Epstein-Barr Virus Infections - diagnosis | Cohort Studies | Multiple sclerosis | Children's hospitals | Calcifediol | Development and progression | Disease susceptibility | Risk factors | Vitamin D | Medical genetics | Genetic research | Brain damage | Epstein-Barr virus | Genetic aspects | Alfacalcidol | Health aspects | Index Medicus | Brain | Pediatrics | Cerebrospinal fluid | Multivariate analysis | Infection | Algorithms | Magnetic resonance imaging | Demyelination | Classification | Histocompatibility antigen HLA | Children | Genotypes | 25-Hydroxyvitamin D
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 9/2013, Volume 57, Issue 6, pp. 794 - 802
Background. The objective of this analysis was to investigate prognostic factors that influence the outcome of Epstein-Barr virus (EBV)—related posttransplant... 
Health outcomes | Immunosuppression | Lymphoproliferative disorders | Mortality | Predisposing factors | Viral diseases | Transplantation | Graft vs host disease | Epstein Barr virus infections | ARTICLES AND COMMENTARIES | Blood | hematopoietic stem cell transplantation | risk factors | Epstein-Barr virus | post-transplant lymphoproliferative disorder | prognostic model | INFECTIOUS DISEASES | MANAGEMENT | PROGNOSTIC-FACTORS | LOAD | SCT | MICROBIOLOGY | IMMUNOLOGY | RECIPIENTS | VERSUS-HOST-DISEASE | REACTIVATION | LYMPHOMA | PTLD | LYMPHOCYTES | Prognosis | Humans | Middle Aged | Child, Preschool | Infant | Epstein-Barr Virus Infections - surgery | Viral Load | Herpesvirus 4, Human - isolation & purification | Adult | Retrospective Studies | Child | Epstein-Barr Virus Infections - epidemiology | Lymphoproliferative Disorders - surgery | Epstein-Barr Virus Infections - virology | Lymphoproliferative Disorders - virology | Risk Factors | Kaplan-Meier Estimate | Europe - epidemiology | Hematopoietic Stem Cell Transplantation | Rituximab | Epstein-Barr Virus Infections - drug therapy | Lymphoproliferative Disorders - epidemiology | DNA, Viral - blood | Adolescent | Lymphoproliferative Disorders - drug therapy | Aged | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Immunologic Factors - therapeutic use | Prescription drugs | Hematology | Stem cells | Drug therapy | Multivariate analysis | Blood diseases | Risk factors | Clinical outcomes | Index Medicus
Journal Article
Cancer, ISSN 0008-543X, 05/2013, Volume 119, Issue 10, pp. 1838 - 1844
Journal Article
Journal Article
Digestive Diseases and Sciences, ISSN 0163-2116, 11/2015, Volume 60, Issue 11, pp. 3399 - 3407
Young age and thiopurine therapy are risk factors for lymphoproliferative disease among patients with inflammatory bowel disease (IBD).The aims of this study... 
Biochemistry, general | Inflammatory bowel disease | Cytomegalovirus | Medicine & Public Health | Infliximab | Hepatology | Gastroenterology | Oncology | Immunosuppressive therapy | Azathioprine | Epstein–Barr virus | Transplant Surgery | UNITED-STATES | CROHNS-DISEASE | LOAD | ULCERATIVE-COLITIS | RISK | T-CELL LYMPHOMA | YOUNG-PATIENTS | QUANTITATIVE-ANALYSIS | REAL-TIME PCR | Epstein-Barr virus | GASTROENTEROLOGY & HEPATOLOGY | Crohn Disease - epidemiology | Polyomavirus Infections - immunology | Multivariate Analysis | Prevalence | Age Factors | Cytomegalovirus Infections - epidemiology | Humans | Child, Preschool | Male | Seroepidemiologic Studies | Cytomegalovirus Infections - immunology | Colitis, Ulcerative - epidemiology | Colitis, Ulcerative - immunology | Viral Load | Czech Republic - epidemiology | Infliximab - adverse effects | Crohn Disease - diagnosis | Cytomegalovirus Infections - virology | Female | Opportunistic Infections - immunology | Colitis, Ulcerative - drug therapy | Odds Ratio | Child | Serologic Tests | Epstein-Barr Virus Infections - epidemiology | Opportunistic Infections - virology | Cross-Sectional Studies | Epstein-Barr Virus Infections - virology | Opportunistic Infections - epidemiology | Epstein-Barr Virus Infections - immunology | Risk Factors | Polyomavirus Infections - epidemiology | Logistic Models | Cytomegalovirus Infections - diagnosis | Crohn Disease - immunology | Opportunistic Infections - diagnosis | Polyomavirus Infections - diagnosis | Colitis, Ulcerative - diagnosis | Polyomavirus Infections - virology | Crohn Disease - drug therapy | Adolescent | Epstein-Barr Virus Infections - diagnosis | Immunosuppressive Agents - adverse effects | Immunocompromised Host | Azathioprine - adverse effects | Analysis | Prevalence studies (Epidemiology) | Ulcerative colitis | Index Medicus | Abridged Index Medicus
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 1/2013, Volume 56, Issue 1, pp. 84 - 92
Background. The epidemiology and morbidity of Epstein-Barr virus (EBV) infection in pediatric renal transplant recipients have been characterized... 
HLA antigens | Pediatrics | Antivirals | Infections | Epstein Barr virus infections | ARTICLES AND COMMENTARIES | Viral load | Epidemiology | Human herpesvirus 4 | Disease risks | Morbidity | immunosuppression | Epstein-Barr virus | pediatric renal transplantation | human leukocyte antigen | post-transplant lymphoproliferative disease | B-LYMPHOCYTES | DIAGNOSIS | INFECTIOUS DISEASES | POSTTRANSPLANT-LYMPHOPROLIFERATIVE-DISORDER | RISK | CLASSIFICATION | MICROBIOLOGY | IMMUNOLOGY | VIRAL LOAD CARRIAGE | SOLID-ORGAN TRANSPLANT | CHRONIC ALLOGRAFT INJURY | EBV | GANCICLOVIR | Prospective Studies | Humans | Immunosuppressive Agents - therapeutic use | Male | Kidney Transplantation - statistics & numerical data | Transplants - statistics & numerical data | Viral Load | Herpesvirus 4, Human - isolation & purification | Epstein-Barr Virus Infections - therapy | Statistics, Nonparametric | Female | Child | Lymphoproliferative Disorders - etiology | Epstein-Barr Virus Infections - epidemiology | Graft Rejection - drug therapy | Epstein-Barr Virus Infections - virology | Antiviral Agents - therapeutic use | Epstein-Barr Virus Infections - immunology | Graft Rejection - prevention & control | Lymphoproliferative Disorders - virology | Herpesvirus 4, Human - immunology | Lymphoproliferative Disorders - epidemiology | Analysis of Variance | Adolescent | Care and treatment | Kidneys | Epstein-Barr virus diseases | Transplantation | Research | Children | Risk factors | Diseases | Transplants & implants | Viruses | Index Medicus
Journal Article